# Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

> **NCT05973318** · PHASE3 · COMPLETED · sponsor: **Jadran Galenski laboratorij d.d.** · enrollment: 110 (actual)

## Conditions studied

- Primary Open Angle Glaucoma of Both Eyes

## Interventions

- **DRUG:** Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- **DRUG:** Cosopt eye drops, 20 mg/mL + 5 mg/mL

## Key facts

- **NCT ID:** NCT05973318
- **Lead sponsor:** Jadran Galenski laboratorij d.d.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-10
- **Primary completion:** 2018-09-17
- **Final completion:** 2018-09-17
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05973318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05973318, "Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05973318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*